Clinical trial · Interventional
Remote Electronic Patient Monitoring in Gastrointestinal Cancer
NCT04030624CI-TRIAL-00048272withdrawnN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Funding discontinued due to changes in corporate structures
Summary
Brief summary (as posted)
The goal of this research study is to evaluate a program that involves remote electronic monitoring of vital signs and symptoms of patients with gastrointestinal cancer who were recently hospitalized at Massachusetts General Hospital or presented to the oncology clinic for an unplanned, urgent visit.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastrointestinal Cancer | Malignant Digestive System Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Remote Electronic Patient Monitoring | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Remote Electronic Patient Monitoring
- description
- * The Remote Electronic Patient Monitoring intervention will entail monitoring of vital sign data and patient reported assessments to address and manage any concerning issues identified. * The Remote Patient Monitoring system uses algorithms that can indicate when patient vitals and patient-reported outcomes have changed. * Automatic patient surveys are sent to the patient with results displayed on the clinician user interface (i.e., dashboard) on a computer located in the clinical area. * Qualitative interviews with patient participants and their oncology clinicians using a semi-structured interview guide will be conducted.
- interventionNames
- Device: Remote Electronic Patient Monitoring
Primary outcomes (1)
- measure
- The Feasibility of Remote Electronic Patient Monitoring Intervention
- timeFrame
- 4 weeks
- description
- The intervention will be deemed feasible if at least 50% (95% confidence interval +/- 13%) of patients agree to participate in the study and sign informed consent, and if participants wear the Remote Electronic Patient Monitoring device ≥ 50% (95% confidence interval +/- 13%) of the time within the two weeks following the baseline time point.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18 or older * Diagnosed with gastrointestinal cancer * Hospitalized at Massachusetts General Hospital (MGH) or presenting to the ambulatory MGH oncology clinic for an unplanned, urgent visit * Planning to receive outpatient care at the MGH Cancer Center * Ability to read and respond to questions in English Exclusion Criteria: * Uncontrolled psychiatric illness or impaired cognition that would interfere with completing study procedures * Enrolled in hospice * Planning to be discharged to any location other than their home
References
Publications (0)
Data not yet available
No reference posted for this study.